Anasen Injection 2 mL (Diclofenac Beta-Dimethylaminoethanol)

Adult administration

As diclofenac beta-dimethylaminoethanol, 90 mg per day is deeply injected into one side of the upper buttock. In severe cases, it may be administered twice a day at 90 mg each time, alternating injection in both buttocks. After the initial phase of treatment, it can be switched to oral tablets or suppositories. The dosage should be adjusted appropriately based on age, condition, and symptoms. To minimize cardiovascular adverse reactions, use the minimum effective dose for the shortest duration.

This medication may increase the risk of gastrointestinal bleeding in individuals who regularly consume three or more alcoholic drinks daily, so it is essential to consult with a doctor or pharmacist. This drug may affect the cardiovascular system and increase the risk of serious thrombotic reactions such as myocardial infarction or stroke; therefore, individuals with cardiovascular diseases or risk factors should be closely monitored. Severe gastrointestinal issues such as ulcers or bleeding may occur, so care must be taken, especially for older adults or those with a history of gastrointestinal disorders. Allergic reactions may manifest as severe chest pain or difficulty breathing; if these symptoms occur, discontinue use immediately and consult medical personnel. When using injectable ampoules, care must be taken to prevent glass fragments from contaminating the solution, especially in children or the elderly. Individuals with peptic ulcers, severe blood disorders, severely impaired liver or kidney function, severe hypertension or heart failure, and those with known allergies to this drug's components should not use this medication. Those who have previously experienced allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs should also avoid using this drug for safety. Before administration, the patient's condition should be thoroughly evaluated, and if necessary, routine blood tests or liver and kidney function tests should be performed to detect any abnormal signs early. This drug should not be used in conjunction with other non-steroidal anti-inflammatory drugs as the risk of side effects may increase. It should be avoided during pregnancy, particularly in the later stages, as it may pose risks to the fetus, and during breastfeeding, it may cause adverse reactions in infants, necessitating either the suspension of breastfeeding or the cessation of the medication. Older adults and children may be more sensitive to the side effects of this drug, so it should be used cautiously at the minimal effective dose.

Serious side effects

• Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness
• Gastrointestinal bleeding, peptic ulcer, bleeding
• Stevens-Johnson syndrome, Lyell syndrome, acute generalized exanthematous pustulosis, toxic epidermal necrolysis, photosensitivity
• Jaundice, liver dysfunction
• Acute renal failure, oliguria, hematuria
• Asthma attack, bronchospasm, dyspnea
• Severe edema associated with high blood pressure
• Severe allergic reactions and Kounis syndrome
• Shock symptoms (chest pain, cold feeling, difficulty breathing

Mild side effects

• Loss of appetite
• nausea
• vomiting
• abdominal pain
• diarrhea
• stomatitis
• thirst
• constipation
• headache
• drowsiness

This medication is sensitive to light, so it must be stored in a container that does not allow light to penetrate. Additionally, to maintain its effectiveness, it is important to store it at room temperature, specifically between 1 and 30 degrees Celsius.

Appearance

A brown ampoule injection containing a transparent solution that is colorless to pale yellow

Package unit

1 ampoule (2 mL) x 50